Myeloid neoplasms with mutated TP53: These neoplasms are new types of myeloid neoplasms, which are further classified as MDS, MDS/AML, and AML depending on TP53 mutations and blast counts. This evidence concerns the gene TP53 and myelodysplastic syndrome.